Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99TCm macroaggregated albumin

British Journal of Radiology

Volumn 70, Issue AUG., 1997, Pages 823-828

  Ho, S ^a   Lau, W Y ^a   Leung, T W T ^a   Chan, M ^a   Chan, K W ^a   Lee, W Y ^a   Johnson, P J ^a   Li, A K C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; MICROSPHERE; TECHNETIUM 99M; YTTRIUM 90;

ARTICLE; CANCER RADIOTHERAPY; COLORECTAL CARCINOMA; HEPATIC ARTERY; HUMAN; LIVER ANGIOGRAPHY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; SHUNTING; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 0030801974     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.70.836.9486047     Document Type: Article

References (20)

1. Friedman MA. Primary hepatocellular cancer: present results and future prospects. Int J Radiat Oncol Biol Phys 1983;9:1841-50.
2. Sherman DM, Weichsebaum R, Order SE, et al. Palliation of hepatic metastases. Cancer 1978;41:2013-17.
3. Yoo HS, Park CH, Suh JH, et al. Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings. Cancer Chemother Pharmacol 1989;23(Suppl):S54-S58.
4. Phillips R, Karnofsky DA, Hamilton LD, et al. Roentgen therapy of hepatic metastases. AJR 1954;71:826-34.
5. Ingold JA, Reed GB, Kaplan HS, et al. Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med 1965;93:200-8.
6. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic liver: distinction based on blood supply. Radiology 1991;178:493-7.
7. Ho S, Lau WY, Leung TWT, et al. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. Eur J Nucl Med 1996;23:947-52.
8. Goldberg JA, Bradnam MS, Kerr DJ, et al. Single photon emission computed tomographic (SPECT) studies of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastases: improved tumour targeting by microspheres with angiotensin II. Nucl Med Comm 1987;8:1025-32.
9. Gyves JW, Zeissman HA, Ensminger WD, et al. Definition of hepatic tumour circulation by single-photon emission computerized tomography (SPECT). J Nucl Med 1984;25:972-7.
10. Leung WT, Lau WY, Ho SKW, et al. Determination of tumour vascularity using selective hepatic angiography compared with intrahepatic-arterial technetium-99m macroaggregated albumin scan in hepatocellular carcinoma. Cancer Chemother Pharmacol 1994;33(Suppl):S33-S36.
11. Leung WT, Lau WY, Ho S, et al. Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin. J Nucl Med 1994;35:70-3.
12. Shepherd FA, Rostein LE, Houle S, et al. A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer 1992;70:2250-4.
13. Gray BN, Burton MA, Kelleher DK, et al. Selective internal radiation (SIR) therapy for treatment of liver metastases: measurement of response rate. J Surg Oncol 1989;42:192-6.
14. Blanchard RJW, Morrow IM, Sutherland JB. Treatment of liver tumours with yttrium-90 microspheres alone. J Can Assoc Radiol 1989;40:206-10.
15. Grady ED. Internal radiation therapy of hepatic cancer. Dis Col Rect 1979;2:371-5.
16. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954;30:969-85.
17. Suzuki T, Sarumaru S, Kawabe K, Honjo I. Study of vascularity of tumours of the liver. Surg Gynecol Obstet 1972;134:27-34.
18. Ariel IM, Padula G. Treatment of asymptomatic metastatic cancer to the liver from primary colon and rectal cancer by intraarterial administration of chemotherapy and radioactive isotopes. J Surg Oncol 1982;20:151-6.
19. Mantravadi RVP, Spigos DG, Tan WS, Felix EL. Intraarterial yttrium-90 in the treatment of hepatic malignancy. Radiology 1982;142:783-6.
20. Ho S, Lau WY, Leung TWT, et al. Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med 1997;24:293-8.